Pulse Biosciences Announces Timing of Rights Offering for Up to $60,000,000
Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ technology, today announced that the Company’s Board of Directors has set the...